Abstract:Abstract Background Tumor-associated macrophages (TAM) are immunosuppressive cells that contribute to impaired anti-cancer immunity. Iron plays a critical role in regulating macrophage function. However, it is still elusive whether it can drive the functional polarization of macrophages in the context of cancer and how tumor cells affect the iron-handing properties of TAM. In this study, using hepatocellular carcinoma (HCC) as a study model, we aimed to explore the effect and mechanism of reduced ferrous iron in TAM. Methods TAM from HCC patients and mouse HCC tissues were collected to analyze the level of ferrous iron. Quantitative real-time PCR was used to assess M1 or M2 signature genes of macrophages treated with iron chelators. A co-culture system was established to explore the iron competition between macrophages and HCC cells. Flow cytometry analysis was performed to determine the holo-transferrin uptake of macrophages. HCC samples from The Cancer Genome Atlas (TCGA) were enrolled to evaluate the prognostic value of transferrin receptor (TFRC) and its relevance to tumor-infiltrating M2 macrophages. Results We revealed that ferrous iron in M2-like TAM is lower than that in M1-like TAM. In vitro analysis showed that loss of iron-induced immunosuppressive M2 polarization of mouse macrophages. Further experiments showed that TFRC, the primary receptor for transferrin-mediated iron uptake, was overexpressed on HCC cells but not TAM. Mechanistically, HCC cells competed with macrophages for iron to upregulate the expression of M2-related genes via induction of HIF-1α, thus contributing to M2-like TAM polarization. We further clarified the oncogenic role of TFRC in HCC patients by TCGA. TFRC is significantly increased in varieties of malignancies, including HCC, and HCC patients with high TFRC levels have considerably shortened overall survival. Also, TFRC is shown to be positively related to tumor-infiltrating M2 macrophages. Conclusions Collectively, we identified iron starvation through TFRC-mediated iron competition drives functional immunosuppressive polarization of TAM, providing new insight into the interconnection between iron metabolism and tumor immunity.

A dietary commensal microbe enhances antitumor immunity by activating tumor macrophages to sequester iron

Dietary commensal wrestles iron from tumor microenvironment to activate antitumoral macrophages

A microbial iron fist to fight tumors

Overcoming the nutritional immunity by engineering iron scavenging bacteria for cancer therapy

Overcoming the nutritional immunity by engineering iron-scavenging bacteria for cancer therapy

Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy

Crosstalk between Macrophages, T Cells, and Iron Metabolism in Tumor Microenvironment

In respond to commensal bacteria: γδT cells play a pleiotropic role in tumor immunity

Microbiota-induced plastic T cells enhance immune control of antigen-sharing tumors

A defined commensal consortium elicits CD8 T cells and anti-cancer immunity

The Species of Gut Bacteria Associated with Antitumor Immunity in Cancer Therapy

The role of iron metabolism in cancer therapy focusing on tumor‐associated macrophages

Vitamin D-dependent microbiota-enhancing tumor immunotherapy

Iron boosts anti-tumor type 1 T-cell responses and anti-PD1 immunotherapy

Lactobacillus rhamnosus GG Orchestrates an Antitumor Immune Response

Combining IL-2-based immunotherapy with commensal probiotics produces enhanced antitumor immune response and tumor clearance

Iron Metabolism in the Tumor Microenvironment—Implications for Anti-Cancer Immune Response

The Impact of Gut Microbiota-Derived Metabolites on the Tumor Immune Microenvironment

Tumor cell-imposed iron restriction drives immunosuppressive polarization of tumor-associated macrophages

Exploring micronutrients and microbiome synergy: pioneering new paths in cancer therapy